Modified One Anastomosis Gastric Bypass (OAGB) Versus Duodenojejunostomy for Treatment of Superior Mesenteric Artery Syndrome: A Randomized Controlled Trial.
Surg Laparosc Endosc Percutan TechOct 1, 2026 (epub)
Clinical ResearchGeneral Surgery
Ahmed A A Y Salem, Mohey R Elbanna, Amr A M Abdel-Alim et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial compared modified one anastomosis gastric bypass (OAGB) to duodenojejunostomy in 20 patients with superior mesenteric artery syndrome. The study found that modified OAGB led to significantly higher quality of life scores at 12 months (59.3±10.0 vs. 42.7±15.9, P =0.014) and lower rates of recurrent vomiting (20% vs. 50%).
Key findings
- Modified OAGB resulted in higher WHOQOL-BREF scores at 12 months (59.3±10.0 vs. 42.7±15.9, P =0.014).
- Patients undergoing modified OAGB had lower rates of recurrent vomiting (20% vs. 50%).
- The average hospital stay was shorter for modified OAGB (4.1±0.32 d vs. 6.8±2.94 d, P =0.017).
Why it matters
The findings suggest that modified OAGB may provide better symptom relief and quality of life for patients with superior mesenteric artery syndrome compared to the traditional duodenojejunostomy, which could influence surgical decision-making.